Congratulations to Dr Yu Yu from Curtin Medical School and the Curtin Health Innovation Research Institute, on being awarded $493,640 through the Innovation Seed Fund for the project ‘Early Detection of Platinum-Chemotherapy Drug Response in Solid Tumour Biopsies’.

The funding will help Dr Yu and her team to develop an early diagnosis tool predicting how cancer patients will respond to chemotherapy. The project focuses initially on ovarian cancer, one of the deadliest cancers with a high incidence of drug resistance and late-stage diagnosis.

The Innovation Seed Fund, funded through the Western Australian Future Health Research and Innovation Fund, supports WA innovators and early-stage start-up companies to develop and commercialise cutting-edge health and medical innovations.

Read more about Dr Yu’s project in our media release.